Artivion, INC Form 4 insider transactions
NYSE
AORT
Artivion, INCArtivion's CEO, James P. Mackin, sold shares of common stock on February 24, 2025, to cover tax withholding obligations related to the vesting of restricted stock units.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP and General Counsel of Artivion, Inc., sold shares of common stock on February 24, 2025, to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
AORT
Artivion, INCArtivion's Chief Commercial Officer, John E. Davis, sold shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units.
NYSE
AORT
Artivion, INCLance A. Berry, Executive VP and CFO of Artivion, Inc., sold 3,259 shares of common stock on February 24, 2025, to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
AORT
Artivion, INCMarshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., reports selling shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.
NYSE
AORT
Artivion, INCArtivion Inc.'s VP, Chief Accounting Officer, Amy Horton, gifted 1,100 common shares to a charity on December 12, 2024.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP and General Counsel at Artivion Inc., sold 8,070 shares of common stock in a recent open market transaction.
NYSE
AORT
Artivion, INCArtivion Inc. files an amendment to correct an administrative error in reporting the number of shares sold to cover tax obligations on December 6, 2024.
NYSE
AORT
Artivion, INCArtivion Inc.'s VP, Chief Accounting Officer, Amy Horton, sold 4,329 shares of common stock to cover tax obligations related to vesting restricted stock units.
NYSE
AORT
Artivion, INCAndrew M. Green, VP of Regulatory at Artivion, Inc., sold 7,618 shares of common stock at $30 per share under a pre-arranged 10b5-1 trading plan.
NYSE
AORT
Artivion, INCAmy Horton, VP, Chief Accounting Officer of Artivion, Inc., reports the sale of 12,430 shares of common stock on October 1, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP, General Counsel of Artivion, Inc., reported the sale of 3,167 shares of common stock at an average price of $26.5538 on August 26, 2024.
NYSE
AORT
Artivion, INCMatthew Getz, VP of Human Resources at Artivion, Inc., reports the sale of common stock units on August 16, 2024.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 2,383 shares of common stock on August 15, 2024, at a price of $25.7629 per share.
NYSE
AORT
Artivion, INCDirector Anthony B. Semedo of Artivion Inc. (AORT) sold 9,709 shares of common stock at a price of $24.99 per share on August 13, 2024.
NYSE
AORT
Artivion, INCDirector Thomas Ackerman acquired 6,289 shares of Artivion, Inc. common stock through the vesting of a restricted stock award.
NYSE
AORT
Artivion, INCDirector Daniel J. Bevevino acquired 6,289 shares of Artivion, Inc. through a restricted stock grant that vests on May 30, 2025.
NYSE
AORT
Artivion, INCDirector Jon W. Salveson reports acquiring 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
AORT
Artivion, INCDirector James Bullock acquired 6,289 shares of Artivion, Inc. common stock through a restricted stock award that vests on May 30, 2025.
NYSE
AORT
Artivion, INCDirector Jeffrey H. Burbank reports acquiring 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
AORT
Artivion, INCDirector Marna Borgstrom reports acquiring and disposing of Artivion, Inc. common stock on May 30, 2024.
NYSE
AORT
Artivion, INCDirector Anthony B. Semedo reports acquisition of 6,289 shares of Artivion Inc. common stock on May 30, 2024, through an RSA grant.
NYSE
AORT
Artivion, INCDirector Elizabeth A. Hoff acquired 6,289 shares of Artivion, Inc. on May 30, 2024, as part of a restricted stock award.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 1,250 shares of common stock at a price of $23.4201 per share on May 10, 2024.
NYSE
AORT
Artivion, INCJean F. Holloway, SVP, General Counsel of Artivion, Inc., sold 979 shares of common stock on May 9, 2024, at a price of $23.785 per share.
NYSE
AORT
Artivion, INCForm 4: Artivion SVP, Clinical & MD Affairs, Marshall S. Stanton, Sells Shares to Cover Tax Obligations
Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., sold 2,183 shares of common stock on March 20, 2024, to cover tax withholding obligations.
NYSE
AORT
Artivion, INCAndrew M. Green, VP Regulatory at Artivion, Inc., sold 1,462 shares of common stock at $20 per share on March 15, 2024, according to a Form 4 filing.
NYSE
AORT
Artivion, INCAndrew M. Green, VP Regulatory at Artivion, Inc., sold 3,994 shares of common stock at $20 per share on March 14, 2024, under a pre-arranged 10b5-1 trading plan.
NYSE
AORT
Artivion, INCMatthew A. Getz, VP of Human Resources at Artivion, Inc., sold 5,000 shares of common stock on March 12, 2024, at an average price of $19.9439 per share.
NYSE
AORT
Artivion, INCAmy Horton, VP and Chief Accounting Officer of Artivion Inc., files an amended Form 4 to correct the number of shares sold to cover tax withholding obligations.